Life Science Investing KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
Life Science Investing KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
Life Science Investing KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
Life Science Investing KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
Life Science Investing ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
Standard Uranium Retains 100% Unencumbered Ownership of the Sun Dog Project Through Conclusion of Property Option Agreement
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea
